SciVision Biotech Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 126.802 million compared to TWD 104.180 million a year ago. Operating income was TWD 31.114 million compared to TWD 23.984 million a year ago. Net income was TWD 31.629 million compared to TWD 22.384 million a year ago. Basic earnings per share from continuing operations was TWD 0.52 compared to TWD 0.37 a year ago. Diluted earnings per share from continuing operations was TWD 0.51 compared to TWD 0.37 a year ago. For the half year, sales was TWD 238.033 million compared to TWD 213.994 million a year ago. Operating income was TWD 64.350 million compared to TWD 64.463 million a year ago. Net income was TWD 56.269 million compared to TWD 58.704 million a year ago. Basic earnings per share from continuing operations was TWD 0.92 compared to TWD 0.96 a year ago. Diluted earnings per share from continuing operations was TWD 0.9 compared to TWD 0.94 a year ago.